Lenisna Skin Booster: A Clinic Guide to This PN-Based Injectable

By the Dr Adams Aesthetics Product Team · Updated September 2026

Lenisna comes up often in the same conversation as Rejuran and other polynucleotide (PN) skin boosters, but clinics new to the product usually want a straight answer to three questions before they add it to a treatment plan: what it’s made from, how it’s positioned against the PN and PDRN boosters already on their menu, and what to check before ordering stock.

What is Lenisna?

Lenisna is a polynucleotide-based skin booster, part of a category of injectables that use purified PN fragments — rather than hyaluronic acid or PDLLA microparticles — to support tissue repair and hydration in the dermis. PN-based boosters are typically positioned around skin regeneration and barrier repair rather than the collagen-stimulation mechanism you’d see in a PDLLA product like Juvelook, or the pure hyaluronic acid bio-remodelling approach used by Profhilo.

As with any imported injectable, formulation details and concentration can differ between manufacturing batches, so the CE certificate and IFU that ship with each Lenisna order are the authoritative reference for your clinical team — not general category descriptions like this one.

Where Lenisna fits on a skin booster menu

If your clinic already stocks a PDLLA-based biostimulator and a pure HA booster, Lenisna is worth considering as the third option for patients specifically presenting with compromised skin barrier function, post-procedure recovery needs, or general dehydration and dullness where regeneration is the priority over volumising or bio-remodelling. Our side-by-side comparison of Juvelook, Lenisna and Profhilo sets out how the three mechanisms differ in practice, which is a useful reference to talk patients through when they ask why you’re recommending one over another.

Who it’s suitable for

PN-based boosters like Lenisna are generally considered for patients with dehydrated, reactive or barrier-compromised skin, including post-laser or post-peel recovery protocols, subject to your own clinical assessment. As with all injectable skin boosters, it should not be administered to patients who are pregnant or breastfeeding, have active infection or inflammation at the injection site, or have a known hypersensitivity to any component of the formulation — always confirm current contraindications against the specific batch IFU rather than general guidance.

Sourcing and safety

Lenisna should be purchased only through a supplier who can provide full batch traceability and CE documentation, and administered exclusively by trained, licensed medical aesthetic practitioners. If you’re onboarding new injectors, the Joint Council for Cosmetic Practitioners and the Save Face register are both useful starting points for training and accreditation standards. We’ve also put together a general guide to verifying genuine aesthetic injectables that covers exactly what documentation to request from any supplier, including us.

Ordering Lenisna

You can check current Lenisna availability, pack sizes and pricing on the Lenisna product page. Every order ships with the manufacturer’s CE certificate and batch documentation.

FAQs

Is Lenisna the same as Rejuran?

They fall into the same broad polynucleotide category, but formulation, concentration and manufacturer differ — always compare the specific IFUs rather than assuming interchangeability.

Can Lenisna be used alongside hyaluronic acid fillers?

Many practitioners sequence PN boosters with HA fillers as part of a broader treatment plan, but timing and technique should follow your own clinical protocol and the product IFU.

How is Lenisna different from a PDLLA booster like Juvelook?

Lenisna works through polynucleotide-driven tissue repair, while Juvelook relies on a biostimulatory foreign-body response from PDLLA microparticles — different mechanisms aimed at overlapping but distinct patient concerns.